Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128598) titled 'Role of ß-Hydroxybutyrate-Mediated Liver-Brain Axis in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Cognitive Dysfunction and Novel Therapeutic Strategies' on July 22.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Hefei Fourth Peoples Hospital
Condition:
Cognitive impairment
Intervention:
Cohort 1:None
Cohort 2:None
Cohort 3:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-22
Target Sample Size: Cohort 1:100;Cohort 2:100;Cohort 3:100;Cohort 4:100;
Countries of Recruitment:
China
To know more, visit https://w...